Goldman Sachs Group Inc Spdr Ser Tr Spdr S&P Biotech E Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Goldman Sachs Group Inc holds 12,740,694 shares of XBI stock, worth $1.17 Billion. This represents 0.21% of its overall portfolio holdings.

Number of Shares

12,740,694

Previous 11,951,617 6.6%

Holding current value

$1.17 Billion

Previous $1.11 Billion 13.6%

% of portfolio

0.21%

Previous 0.19%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$90.87 - $102.43 $71.7 Million - $80.8 Million	789,077 Added 6.6%	12,740,694 $1.26 Billion
Q2 2024 Aug 13, 2024	BUY	$82.22 - $94.12 $170 Million - $195 Million	2,069,350 Added 20.94%	11,951,617 $1.11 Billion
Q1 2024 May 15, 2024	SELL	$87.05 - $102.89 $24.4 Million - $28.8 Million	-279,842 Reduced 2.75%	9,882,267 $938 Million
Q4 2023 Feb 13, 2024	SELL	$64.12 - $90.86 $171 Million - $243 Million	-2,669,895 Reduced 20.81%	10,162,109 $907 Million
Q3 2023 May 14, 2024	BUY	$71.88 - $85.76 $192 Million - $229 Million	2,669,895 Added 26.27%	12,832,004 $937 Million
Q3 2023 Nov 14, 2023	BUY	$71.88 - $85.76 $181 Million - $216 Million	2,523,251 Added 24.48%	12,832,004 $937 Million
Q2 2023 May 14, 2024	BUY	$75.38 - $90.23 $391 Million - $468 Million	5,185,843 Added 101.23%	10,308,753 $858 Million
Q2 2023 Aug 14, 2023	BUY	$75.38 - $90.23 $391 Million - $468 Million	5,185,843 Added 101.23%	10,308,753 $858 Million
Q1 2023 May 14, 2024	BUY	$73.13 - $91.97 $927,654 - $1.17 Million	12,685 Added 0.25%	5,122,910 $390 Million
Q1 2023 May 11, 2023	BUY	$73.13 - $91.97 $927,654 - $1.17 Million	12,685 Added 0.25%	5,122,910 $390 Million
Q4 2022 May 14, 2024	BUY	$76.72 - $85.66 $6.94 Million - $7.75 Million	90,486 Added 1.8%	5,110,225 $424 Million
Q4 2022 Feb 13, 2023	BUY	$76.72 - $85.66 $6.94 Million - $7.75 Million	90,486 Added 1.8%	5,110,225 $424 Million
Q3 2022 May 14, 2024	SELL	$75.06 - $94.9 $118 Million - $150 Million	-1,578,160 Reduced 23.92%	5,019,739 $398 Million
Q3 2022 Nov 10, 2022	SELL	$75.06 - $94.9 $118 Million - $150 Million	-1,578,160 Reduced 23.92%	5,019,739 $0
Q2 2022 May 14, 2024	SELL	$62.81 - $96.09 $224 Million - $342 Million	-3,564,210 Reduced 35.07%	6,597,899 $490 Million
Q2 2022 Aug 15, 2022	BUY	$62.81 - $96.09 $56.3 Million - $86.1 Million	896,136 Added 15.72%	6,597,899 $490 Million
Q1 2022 May 16, 2022	SELL	$81.07 - $115.44 $193 Million - $275 Million	-2,381,440 Reduced 29.46%	5,701,763 $512 Million
Q4 2021 Feb 14, 2022	BUY	$108.77 - $134.15 $134 Million - $165 Million	1,229,149 Added 17.93%	8,083,203 $905 Million
Q3 2021 Nov 10, 2021	BUY	$118.69 - $138.49 $814 Million - $949 Million	6,854,054 New	6,854,054 $862 Million

Others Institutions Holding XBI

# of Institutions

927

Shares Held

101M

Call Options Held

28.4M

Put Options Held

33.4M

View Full List

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

More about XBI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Spdr Ser Tr Spdr S&P Biotech E Transaction History